Lexpos News

Regular occurrences of abuse against community pharmacy teams are making their working life increasingly difficult, and at times dangerous, new research from Community Pharmacy England has demonstrated. A recent survey of more than 3,000 pharmacy premises found that: More than half (55%) of pharmacies had experienced verbal abuse in the preceding six months, with three-quarters [...]

The post Racist, hostile, verbal and physical abuse of pharmacy teams now a regular occurrence appeared first on Community Pharmacy England.

Pharmacy owners have until the end of Tuesday 31st March 2026 to have their evidence to demonstrate meeting the 2025/26 Pharmacy Quality Scheme (PQS) domains that they have claimed for. Pharmacy owners were required to complete a PQS declaration between 9am on 2nd February 2026 and 11.59pm on 27th February 2026. However, pharmacy owners have [...]

The post PQS: 31st March deadline approaches appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (24/03/2026) confirmed the following list of price concessions for March 2026: Drug Pack size Price concession Adapalene 0.1% cream 45 £18.26 Adapalene 0.1% gel 45 £18.26 Alfuzosin 2.5mg tablets 60 £6.67 Amlodipine 2.5mg tablets 28 £3.88 Aripiprazole 15mg tablets 28 £1.02 Aspirin 75mg dispersible tablets 28 [...]

The post March 2026 Price Concessions 2nd Update appeared first on Community Pharmacy England.

The Royal Pharmaceutical Society (RPS) – supported by Community Pharmacy England, charities and patient groups – is calling on the Government to make headway in introducing community pharmacist flexibilities and addressing reimbursement issues that can delay access to medicines. Medicines Shortages: One Year On assesses progress on supply issues since the launch of the RPS’s [...]

The post Call for swift movement on flexibilities and reimbursement changes to tackle supply issues appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Recall: Hibiwash® 500ml (Regent Medical Limited / Mölnlycke Health Care) Drug alert number: EL(26)A/15 Date issued: 23 March 2026 Mölnlycke Health Care are recalling specific batches of Hibiwash® due to microbial contamination at the manufacturing facility, following routine weekly microbiological monitoring. DMRC reference number: DMRC-38814497 Company name:Regent Medical Limited / Mölnlycke Health [...]

The post MHRA Class 2 Medicines Recall: Hibiwash® 500ml (Regent Medical Limited / Mölnlycke Health Care) appeared first on Community Pharmacy England.